InvestorsHub Logo
Followers 131
Posts 14996
Boards Moderated 0
Alias Born 06/04/2018

Re: None

Sunday, 12/08/2019 9:31:22 AM

Sunday, December 08, 2019 9:31:22 AM

Post# of 246
News: $REGN First Clinical Data for REGN5458 (BCMAxCD3) Show Positive Preliminary Results in Multiple Myeloma

TARRYTOWN, N.Y. , Dec. 8, 2019 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.  (NASDAQ: REGN ) today announced initial clinical data for REGN5458, a BCMAxCD3 bispecific antibody, in patients with relapsed or refractory (R/R) multiple myeloma. BCMA (B-cell maturation antigen) is...

Read the whole news REGN - First Clinical Data for REGN5458 (BCMAxCD3) Show Positive Preliminary Results in Multiple Myeloma
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent REGN News